Crescel's Skin Renewal Cream Outperforms Standard Treatment for Rosacea

Crescel's Positive Findings on Biobotanical Skin Renewal Cream

Crescel LLC, a leader in science and technology innovation, has shared groundbreaking results from a recent double-blind, randomized clinical trial about its biobotanical Skin Renewal Cream. Conducted under the guidance of a top dermatologist, this trial specifically evaluated the cream's effectiveness for rosacea, a common and often distressing chronic inflammatory skin condition. In a comparison with the standard treatment, which included metronidazole-based combinations, Crescel’s cream proved to be superior in clinical outcomes.

Study Overview

The clinical trial involved 60 adult participants ranging from mild to severe cases of rosacea. Over a 12-week period, these subjects were administered either the Crescel Skin Renewal Cream or a topical metronidazole (Metrocream®) along with a CeraVe® moisturizer—commonly accepted treatment options in dermatology. The study assessed changes in redness and inflammatory lesions at specific intervals: baseline, 4, 8, and 12 weeks.

Clinical Outcomes

The outcomes of the trial were both encouraging and statistically significant. The Crescel Skin Renewal Cream group showed a remarkable reduction of 54% in skin redness (erythema) after 12 weeks, compared to a 23% reduction in the standard treatment group. The findings for inflammatory lesions were even more striking, with a 74% decrease observed at the 8-week mark that was sustained through the final evaluation. In contrast, the standard care group demonstrated only a 17% reduction, which lacked statistical significance.

Tolerability

Importantly, the Crescel Skin Renewal Cream was exceptionally well tolerated among participants. During the study, there were no adverse effects or clinically relevant issues reported, including irritation or dryness, which are common complaints among topical treatments. This aspect highlights the potential for Crescel's formula to provide effective relief without the burdens of typical side effects.

Product Features

Crescel's Skin Renewal Cream is not just a standard topical treatment; it combines naturally derived ingredients within an advanced microemulsion delivery system designed to promote healthy skin function. Additionally, it has earned recognition from both the National Rosacea Society and the National Psoriasis Foundation, validating its therapeutic performance.

Expert Insights

Peter J. Passalacqua, Jr., Co-Founder, Chairman, and CEO of Crescel, emphasized the significance of these findings, stating, “These results advocate for a new and more effective management strategy for rosacea.” Furthermore, Dr. Roberta Shapiro, a respected figure in regenerative medicine from Columbia University, shared her astonishment: “Crescel's healing capabilities are unparalleled. In my 30 years of practice, I have never encountered anything comparable.”

Future Directions

In light of these positive results, Crescel is committed to furthering research on their Skin Renewal Cream, examining its benefits for other skin conditions, including psoriasis, eczema, acne, and diabetic ulcers. These trial results will soon be submitted for publication in a peer-reviewed medical journal, allowing for greater transparency and recognition within the medical community.

For those interested, Crescel Skin Renewal Cream is readily available for purchase online at www.crescel.com. As the brand gains traction, additional studies may enhance its reputation as a go-to solution for individuals suffering from rosacea and potentially other skin ailments.